SCIENCE BOND

Posts

Showing posts with the label cancer

A new cancer drugs significantly slow the spread of deadly recurrent breast cancers

Data presented at the world's biggest cancer conference showed that time without a tumour progressing increased from 15 months to 25 months with palbiciclib. However, fears have been raised that women in the UK will not benefit because of the cost. Most women with breast cancer have tumours that are fuelled by oestrogen. So after treatment, women often take drugs to block the sex hormone and stop the cancer coming back. But sometimes this preventative measure fails and the tumours that come back are difficult to treat. Palbociclib, developed by Pfizer, disrupts a pair of proteins - called CDK4 and CDK6 - which promote tumour growth. The trial on 666 women, presented at the American Society of Clinical Oncology, showed the drugs had "significant clinical benefit". Dr Nick Turner, from the Royal Marsden Hospital in London and involved in earlier research on the drug, told . The results are pretty impressive and we hope they will lead to the dru...

Excitement at new cancer treatment

White blood cells were taken from patients with leukaemia, modified in the lab and then put back. But the data has not been published or reviewed and two patients are said to have died from an extreme immune response. Experts said the trial was exciting, but still only "a baby step." The news bubbled out of the American Association for the Advancement of Science's annual meeting in Washington DC. The lead scientist, Prof Stanley Riddell from the Fred Hutchinson Cancer Research Centre in Seattle, said all other treatments had failed in these patients and they had only two-to-five months to live. He told the conference that: "The early data is unprecedented."In the trial, cells from the immune system called killer t-cells were taken out of dozens of patients. The cells normally act like bombs destroying infected tissue. The researchers genetically modified the t-cells to engineer a new targeting mechanism - with the technical name of chimeric antigen...

Mum can't wait for chemo after baby born 12 weeks early

Ally Louise Smith was born by C-section on Friday weighing just 2lb 5oz after her mother, Heidi Loughlin, was told she had to bring her treatment forward."I want to fast-forward now until March when she will be coming home and my chemo will be over," she told.Photographs of Ally, who is being treated in the neo natal intensive care unit, were released on Tuesday. Ms Loughlin, a Metropolitan Police officer, from Portishead, North Somerset, told "It's almost like lifting a piece of toast, that's how tiny she feels. "She came out crying, which we really didn't expect because she is so little."Ms Loughlin found out she had inflammatory breast cancer when she was 13 weeks pregnant. Doctors gave her the option of terminating the pregnancy to begin aggressive chemotherapy. But Ms Loughlin, who also has two little boys, decided to have the less aggressive chemotherapy to give the baby the best chance. After the treatment failed, doctors sai...

An annual blood test may cut ovarian cancer deaths by a fifth, doctors say

Ovarian tumours are often deadly as they are caught too late. A 14-year study on 200,000 women, published in the Lancet, has been welcomed as a potentially landmark moment in cancer screening. But the researchers and independent experts say it is still too soon to call for mass screening because of concerns about the analysis. Ovarian cancer is difficult to pick up as symptoms, including abdominal pain, persistent bloating and difficulty eating, are common in other conditions.The UK Collaborative Trial of Ovarian Cancer Screening is one of the biggest clinical trials ever conducted and is supposed to give the definitive verdict on screening. It monitored levels of a chemical called CA125 in women's blood. Doctors tracked changes in the levels of CA125, which is produced by ovarian tissue, over time and if levels became elevated then the women were sent for further tests and ultimately surgery. The results are now in, but the interpretation is a ...

The UK paying less for new cancer drugs, according to a report in The Lancet Oncology

While the UK, Greece, Spain and Portugal pay the least, on average, for the drugs they use, Germany, Sweden and Switzerland pay the most. The authors said more transparency was needed because some countries risked overpaying for drugs. The pharmaceutical industry said the UK was getting a fair deal on medicines. Prices of cancer drugs have risen steeply in recent years, placing major stress on many healthcare systems, including the NHS. The report said drugs had accounted for nearly a third of the EU's 51 billion euro (£37bn) cancer healthcare spending in 2009. And the researchers then compared the 2013 price of 31 cancer drugs in 18 high-income countries, including the UK, Australia, New Zealand, France, Greece, Switzerland, Sweden and Portugal. Prices in Greece were the lowest for 14 out of the 24 cancer drugs available there. The price of drugs in the UK was also low. Prices of drugs in Switzerland, Germany and Sweden were frequently...

Pigeons distinguishing breast cancer like as humans

The actual pigeons could generalise precisely what they learned, correctly distinguishing tumours within invisible microscope images. In addition, they performed well with a particular mammogram-classifying task, though an extra mammogram analyze (recognising shady lumps) turned out way too tough. The actual pigeons' capacity may help increase completely new image-based analysis technological know-how. Probable zero bigger than the tip of this catalog little finger, the actual pigeon's human brain on the other hand provides remarkable functions. Pigeons can easily recognize identities along with emotive expressions about human looks, letters on the alphabet, misshapen drug products, and also art simply by Monet compared to Picasso, inches stated Prof Edward Wasserman from your School regarding Iowa, the co-author on the review. "Their aesthetic storage volume is every bit as remarkable, which has a established remember in excess of 1, 900 images. inches...

First time doctors breached the human brain's protective layer to deliver cancer-fighting drugs

The Canadian team used tiny gas-filled bubbles, injected into the bloodstream of a patient, to punch temporary holes in the blood-brain barrier. A beam of focused ultrasound waves applied to the skull made the bubbles vibrate and push their way through, along with chemotherapy drugs. Six to 10 more patients will undergo the same procedure as part of a trial. Experts said the experimental technique used at Sunnybrook Health Sciences Centre was exciting because it meant doctors might be able to give cancer patients potent drugs that otherwise would not work. The same non-invasive method could also be used for other brain diseases, such as dementia and Parkinson's. But many more safety studies are needed, they say. Animal trials have produced some results, but it is not yet clear whether the treatment would work or have side-effects. Blood-brain barrier The blood-brain barrier keeps pathogens and toxins away from the central nervous system...

A man died with due to tapeworm tumour

A man has died with tumours made of cancerous parasitic worm tissue growing in his organs, doctors report. The patient had HIV and his weakened immune system allowed the worm-cancer to flourish. The unusual case was diagnosed through a collaboration between the US Centers for Disease Control and the UK's Natural History Museum. Doctors said the case, detailed in the New England Journal of Medicine, was "crazy" and unusual. Colombian doctors had tried to diagnose the 41-year-old man in 2013. He had what appeared to be normal tumours, some more than 4 cm across, in his lungs, liver and elsewhere in his body. But on closer inspection the cancerous cells were clearly not human - they were tiny at just a tenth of the size of a human cell. "It didn't really make sense," said Dr Atis Muehlenbachs, who picked up the "crazy" case at the US Centers of Disease Control.He ran through several theories including shrinking human cancer cells or ev...

Designer cells reverse one-year-old's cancer

One-year-old Layla Richards, from London, had incurable aggressive leukaemia only five months ago. Doctors used "designer immune cells" to fight the cancer and say her improvement was "almost a miracle". It is too soon to know if she has been cured, but her progress already marks a huge moment for the field. Layla was three months old when she was diagnosed with the condition. As often happens with very young babies, chemotherapy and a bone marrow transplant failed to cure her.Doctors had nothing left to offer and, the day before her first birthday, her family were advised to go through palliative care. But Layla's dad Ashleigh refused to give up. He told "I didn't want to go down that road, I'd rather that she tried something new and I took the gamble. "And this is her today standing laughing and giggling, she was so weak before this treatment, it was horrible and I'm just thankful for this opportunity."Dr Paul Veys,...

Prostate cancer drug show low overall success

The study, at the Institute of Cancer Research in London, took place on 49 men with untreatable cancer. The drug, olaparib, had low overall success, but slowed tumour growth in 88% of patients with specific DNA mutations. Cancer Research UK said the trial was exciting. The future of cancer medicine is treating cancers by their mutated DNA rather than what part of the body they are in. The breast cancer drug Herceptin is already used only in patients with specific mutations. Olaparib targets mutations that change the way DNA is repaired.The trial results, published in the New England Journal of Medicine, showed the drug worked in 14 out of 16 men with such mutations. Levels of Prostate Specific Antigen, which is produced by tumours, was more than halved and there were also significant falls in the number of prostate cancer cells detected in the blood and in the size of secondary tumours. Patients responded to the drug for between six months and near...

Eating processed meats too much can cause cancer, WHO

Processed meat Its report said 50g of processed meat a day - less than two slices of bacon - increased the chance of developing colorectal cancer by 18%. Meanwhile, it said red meats were "probably carcinogenic" but there was limited evidence. The WHO did stress that meat also had health benefits. Cancer Research UK said this was a reason to cut down rather than give up red and processed meats. And added that an occasional bacon sandwich would do little harm. What is processed meat? Processed meat has been modified to either extend its shelf life or change the taste and the main methods are smoking, curing, or adding salt or preservatives. Sausages Simply putting beef through a mincer does not mean the resulting mince is "processed" unless it is modified further. Processed meat includes bacon, sausages, hot dogs, salami, corned beef, beef jerky and ham as well as canned meat and meat-based sauces.It is the chemicals invo...

Arm mole count skin cancer risk

Numbering moles on the right arm was observed to be a decent pointer of aggregate moles on the body. More than 10 demonstrates five times the typical danger. The study, distributed in the British Journal of Dermatology, utilized information from 3,000 twins as a part of the UK. GPs could utilize the discoveries to recognize those most at danger, it said. Melanoma is a kind of skin tumor influencing more than 13,000 individuals in the UK every year. It creates from strange moles, so the danger of being determined to have a melanoma is connected to the quantity of moles a patient has. Scientists from King's College London concentrated on a huge gathering of female twins over a time of eight years, gathering data on skin sort, spots and moles on their bodies. Subsequent to rehashing the activity on a littler gathering of around 400 men and ladies with melanoma, they thought of a snappy and simple approach to survey the danger of ski...

Elephants defense against low cancer forming discovered

Elephants have improved protections against malignancy that can forestall tumors shaping, say researchers. They were attempting to clarify why the creatures have lower levels of disease than would be normal by their size. The group at the University of Utah said "nature has effectively made sense of how to forestall growth" and plan to devise new medicines. Be that as it may, specialists said the emphasis ought to be on the "silly" and "crazy" things people do to build hazard. There is a line of reasoning that says each cell can get to be malignant so the a greater amount of them you have, the more probable you are to get disease. So if an elephant has 100 times the same number of cells as a man then the storage compartment swinging well evolved creatures ought to be 100 times more inclined to have the illness. But then the investigation, distributed in the Journal of the American Medical Association, indicated just 5% of elephants kick the...

Two new therapies of advanced kidney cancer could change treatment of the disease, say experts

Both drugs increased survival in trials which are also published in the New England Journal of Medicine.One drug takes the brakes off the immune system while the other stops growth signals in the tumour. Cancer Research UK said the developments will "greatly expand the arsenal" of available drugs. Kidney cancer is the eighth most common cancer in the UK and survival rates plummet if it is caught late. Once the tumour has spread to other parts of the body then only one-in-10 people live for five years after diagnosis. It's another big day for immunotherapy for cancerDr James Larkin, Royal Marsden Hospital The first trial, called Checkmate 025, used the immunotherapy drug nivolumab. It is one of a suite of "checkpoint inhibitors" being developed by pharmaceutical companies that stop cancers turning off the immune system. They have already been proven effective in skin and lung cancers. The trial on 821 patients showed average...